From: Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease
Treatment | SNP | MAF controls [31] | MAF IBD [31] | MAF cohort |
---|---|---|---|---|
IRGM | C | 0.13 | 0.18 | 0.14 |
ATG16L1 | T | 0.48 | 0.40 [44] | 0.57 |
NOD2 | T, C, C | – | – | |
rs2066844 | T | 0.07 | 0.14 | 0.07 |
rs2066845 | C | 0.01 | 0.05 | 0.03 |
rs2066847 | C | 0.02 | 0.11 | 0.04 |
XBP1 | C, protective | 0.04 | 0.04 | 0.05 |
LRRK2/MUC19 | T | 0.02 | 0.03 | 0.03 |
CCR6 | A | 0.47 | 0.48 | 0.50 |
IL23R | G, protective | 0.08 | 0.02 | 0.04 |
STAT3 | T | 0.42 | 0.41 | 0.38 |
NCF4 | C | 0.33 | 0.31 |